期刊文献+

脱氧佛波醇乙酸酯通过激活PKC/ERK通路诱导急性髓系白血病细胞分化 被引量:2

12-Deoxyphorbol 13-acetate inducing acute myeloid leukemia cell differentiation through PKC/ERK pathway
原文传递
导出
摘要 目的研究脱氧佛波醇乙酸酯(12-deoxyphorbol 13-acetate,Prostratin,DPA)对人急性髓系白血病(AML)细胞株HL-60、NB4和U937细胞分化的影响,并证明其通过激活蛋白激酶C/胞外信号调节激酶(PKC/ERK)通路诱导细胞分化。方法 1μmol/L DPA作用HL-60细胞3 d后观察细胞形态的改变;不同剂量的DPA作用HL-60、NB4、U937细胞24 h后,流式细胞仪检测细胞分化表面标志变化;Western印迹检测ERK蛋白磷酸化的改变;流式细胞仪检测丝裂原活化蛋白激酶激酶(MEK)抑制剂和PKC抑制剂对细胞分化表面标志的影响;Western印迹检测MEK抑制剂和PKC抑制剂对ERK蛋白磷酸化的影响。结果 DPA可诱导HL-60细胞出现白血病细胞分化的形态。DPA剂量依赖性地诱导AML细胞CD11b表达。DPA在诱导分化剂量范围内可剂量依赖性地引起ERK磷酸化。MEK化学小分子抑制剂U0126可完全抑制DPA引起的ERK磷酸化和CD11b表达;PKC非选择性抑制剂GFX可完全抑制DPA引起的ERK磷酸化和CD11b表达。结论 DPA其通过激活PKC/ERK通路能够明显诱导白血病细胞分化。 ObjectiveTo explore the effect of 12-deoxyphorbol 13-acetate(Prostratin,DPA) on cell differentiation in acute myeloid leukemia(AML) cell lines,and to prove that the mechanism of action is through PKC/ERK pathway.Methods HL-60 cells were cultured with 1 μmol/L DPA,and cell morphology was observed by microscope after 3 days.AML cells were cultured with varying concentrations of DPA.After 24 h of treatment,the CD11b expression level was determined by flow cytometry.The protein expression of phospho-ERK was detected by Western blot.The effect of U0126 and GFX on HL-60 cells' CD11b expression was measured by flow cytometry.The effect of U0126 and GFX on AML cells' phospho-ERK expression was measured by Western blot.ResultsDPA could induce HL-60 cells differentiation and exhibit a typical cell morphology.DPA up-regulated the expression of CD11b in AML cells in a concentration-dependent manner,and exhibited a dose dependent up-regulatory effect on phospho-ERK expression in the same varying concentrations.Both U0126 and GFX inhibited the expression of CD11b and phospho-ERK induced by DPA.ConclusionDPA can induce significant cell differentiation of AML cells.The underlying mechanisms may be through activating PKC/ERK pathway.
出处 《军事医学》 CAS CSCD 北大核心 2011年第6期416-419,458,共5页 Military Medical Sciences
基金 "重大新药创制"科技重大专项资助项目(2009ZX09103-406)
关键词 脱氧佛波醇乙酸酯 白血病 髓样 急性 细胞分化 蛋白激酶C HL-60细胞 PKC/ERK通路 流式细胞术 12-deoxyphorbol 13-acetate leukemia myeloid acute cell differentiation protein kinase C HL-60 cells PKC/ERK pathway flow cytometry
  • 相关文献

参考文献17

  • 1李园,胡亮钉,陈虎.急性髓系白血病干细胞的研究现况与临床应用[J].中国实用内科杂志,2007,27(6):466-468. 被引量:4
  • 2Krisztina B,Patricia SL.Differential selectivity of ligands for theCla and Clb phorbol ester binding domains of protein kinase Cδ:possible correlation with tumor-promoting activity. Cancer Research . 1998
  • 3Hezareh M,Moukil MA.Mechanisms of HIV receptor and co-re-ceptor down-regulation by prostratin:role of conventional and no-vel PKC isoforms. Antiviral Chemistry and Chemotherapy . 2004
  • 4S. J. Collins.Retinoic acid receptors, hematopoiesis and leukemogenesis. Current Opinion in Hematology . 2008
  • 5Joseph Kulkosky,Derek M.Culnan,,Jeanette Roman,Geethanjali Dornadula,Matthias Schnell,Michael R.Boyd,,Roger J.Pomerantz.Prostratin:activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART. Blood . 2001
  • 6Finzi D,Hermankova M,Pierson T,et al.Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science . 1997
  • 7M. Savona,M. Talpaz.Getting to the stem of chronic myeloid leukaemia. Nature Reviews Cancer . 2008
  • 8BIANCOTTO A,GRIVEL J C.GONDOIS-REY F,et al.Dual role of prostratin in inhibition of infection and reactivation of hu- man immunodeficiency virus from latency in primary blood Lymph- oid tissue. Journal of Virology . 2004
  • 9Gustafson,KR,Cardellina,JH,2nd,McMahon,JB,Gulakowski,RJ,Ishitoya,J,Szallasi,Z,Lewin,NE,Blumberg,PM,Weislow,OS,Beutler,JA et al.A nonpromoting phorbol from the samoan medicinal plant Homalanthus nutans inhibits cell killing by HIV-1. Journal of Medicinal Chemistry . 1992
  • 10Gulakowski,RJ,McMahon,JB,Buckheit,RW,Jr,Gustafson,KR,Boyd,MR.Antireplicative and anticytopathic activities of prostratin,a non-tumor-promoting phorbol ester,against human immunodeficiency virus (HIV). Antiviral Research . 1997

二级参考文献10

  • 1Dash A,Gilliland DG.Molecular genetics of acute myeloid leukaemia[J].Best Pract Res Clin Haematol,2001,14:49-64.
  • 2Hasse D,Feuring BM,Konemann S,et al.Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD+34 subpopulations[J].Blood,1995,86:2906-2912.
  • 3Mehrotra B,George TI,Kavanau K,et al.Cytogenetically aberrant cells in the stem cell compartment(CD+34 Lin-)in acute myeloid leukemia[J].Blood,1995,86:1139-1147.
  • 4Terpstra W,Prins A,Ploemacher RE,et al.Long term leukemia-initiating capability of a CD-34 subpopulation of acute myeloid leukemia[J].Blood,1996,87:2187-2194.
  • 5Wei G,Joseph L,Lasky Ⅲ,et al.Cancer stem cells[J].Pediat Res,2006,59:59-64.
  • 6Lapidot T,Sirard C,VormoorJ,et al.A cell initiating human acute myeloid leukemia after transplantation into SCID mice[J].Nature,1994,367:645-648.
  • 7Blair A,Hogge DE,Sutherland HJ.Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD+34 CD-71/HLA-DR-[J].Blood,1998,92:4325-4335.
  • 8CT Jordan.Unique molecular and cellular features of acute myelogenous leukemia stem cells[J].Leukemia,2002,16:559-562.
  • 9Terpstra W,Ploemacher RE,Prins A,et al.Fluorouracil selectively spares acute myeloid leukemia cells with long term growth abilities in immunodeficient mice and in culture[J].Blood,1996,88:1944-1950.
  • 10Guzman ML,Upchurch D,Grimes B,et al.Nuclear factor-kappa B is constitutively activated in primitive human acute myelogenous leukemia cells[J].Blood,2001,98:2301-2307.

共引文献3

同被引文献18

  • 1赵中夫,赵正保.巴豆油各分离组份体外抗结核分枝杆菌实验研究[J].长治医学院学报,2006,20(1):1-3. 被引量:9
  • 2McCulloch EA.Stem cells in normal and leukemic hemopoiesis[J].Blood,1983,62(1):1-13.
  • 3Jemal A,Bray F,Center MM,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61(2):69-90.
  • 4Wang ZY,Chen Z.Acute promyelocytic leukemia: from highly fatal to highly curable[J].Blood,2008,111(5):2505-2515.
  • 5Nowak D,Stewart D,Koeffler HP.Differentiation therapy of leukemia: 3 decades of development[J].Blood,2009,113(16):3655-3665.
  • 6Sanz MA,Lo-Coco F.Modern approaches to treating acute promyelocytic leukemia[J].J Clin Oncol,2011,29(5):495-503.
  • 7Chabner BA,Hande KR,Drake JC.Ara-C metabolism; implications for drug resistance and drug interactions[J].Bull Cancer,1979,66(1):89-92.
  • 8Warrilow D,Gardner J.HIV type 1 inhibition by protein kinase C modulatory compounds[J].AIDS Res Hum Retroviruses,2006,22(9):854-864.
  • 9Hezareh M,Moukil MA Szanto I,et al.Mechanisms of HIV receptor and co-receptor down-regulation by Prostratin: role of conventional and novel PKC isoforms[J].Antivir Chem Chemother,2004,15(4):207-222.
  • 10E1-Mekkawy S, Meselhy M R, Nakamur N, et al. Anti- HIV-1 phorbol esters from the seeds of Croton tiglium [ J ]. Phytochemistry, 2000,53 ( 4 ) :457-464.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部